The Inhibition of the Histone Methyltransferase EZH2 by DZNEP or SiRNA Demonstrates Its Involvement in MGMT, TRA2A, RPS6KA2, and U2AF1 Gene Regulation in Prostate Cancer

OMICS. 2020 Feb;24(2):116-118. doi: 10.1089/omi.2019.0162. Epub 2019 Dec 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Modification Methylases / genetics*
  • DNA Modification Methylases / metabolism
  • DNA Repair Enzymes / genetics*
  • DNA Repair Enzymes / metabolism
  • Enhancer of Zeste Homolog 2 Protein / antagonists & inhibitors*
  • Enhancer of Zeste Homolog 2 Protein / genetics*
  • Enhancer of Zeste Homolog 2 Protein / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / metabolism
  • RNA, Small Interfering / genetics*
  • Ribosomal Protein S6 Kinases, 90-kDa / genetics*
  • Ribosomal Protein S6 Kinases, 90-kDa / metabolism
  • Splicing Factor U2AF / genetics*
  • Splicing Factor U2AF / metabolism
  • Tumor Suppressor Proteins / genetics*
  • Tumor Suppressor Proteins / metabolism

Substances

  • RNA, Small Interfering
  • Splicing Factor U2AF
  • Tumor Suppressor Proteins
  • U2AF1 protein, human
  • DNA Modification Methylases
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein
  • MGMT protein, human
  • Ribosomal Protein S6 Kinases, 90-kDa
  • ribosomal protein S6 kinase, 90kDa, polypeptide 3
  • DNA Repair Enzymes